Jitodapa VIME 10/100/500 Tablet (10 Tab)

Jitodapa VIME 10/100/500 Tablet Overview:

Jitodapa VIME 10/100/500 Tablet is an antidiabetic medication used to provide comprehensive blood sugar management in adults with type 2 diabetes mellitus.

It integrates three active antidiabetic agents - Vildagliptin, Dapagliflozin, and Metformin Hydrochloride that work through distinct pathways to control high blood sugar levels when diet, exercise, and other treatments are insufficient.

In Type 2 Diabetes, the body either fails to produce enough insulin or cannot use it properly. The condition occurs because the liver produces too much glucose.

Jitodapa VIME 10/100/500 Tablet helps lower uncontrolled blood sugar by stimulating the natural production of insulin, improving the body's ability to use that insulin efficiently, and excreting excess glucose through urine.

Furthermore, it is important to know that the medication is only indicated for Type 2 diabetes mellitus and not for Type 1 diabetes or diabetic ketoacidosis.

Composition:

Each uncoated bilayered tablet contains- Vildagliptin (As sustained release form): 100 mg, Dapagliflozin propanediol monohydrate eq. to Dapagliflozin: 10 mg, Metformin Hydrochloride (As sustained release form): 500 mg and Excipients q.s.

Colour: Quinoline Yellow

Uses & Benefits of Jitodapa VIME 10/100/500 Tablet:

Jitodapa VIME 10/100/500 Tablet is primarily prescribed to treat type 2 diabetes, also known as non-insulin-dependent diabetes mellitus (NIDDM).

It also helps lower the risk of long-term diabetes-related complications such as kidney damage, nerve problems, and cardiovascular events.

How Does Jitodapa VIME 10/100/500 Tablet Work:

The active ingredients in Jitodapa VIME 10/100/500 Tablet are Vildagliptin, Dapagliflozin, and Metformin Hydrochloride, which target multiple organ systems to lower blood glucose.

Vildagliptin belongs to the group of medicines called DPP-4 inhibitors. It works by increasing incretin hormone levels (GLP-1 and GIP), which enhance insulin secretion when blood sugar is high and suppress glucagon secretion after meals.

Dapagliflozin is an SGLT2 inhibitor that works in the kidneys by blocking the reabsorption of filtered glucose, allowing excess sugar to be excreted through urine.

Metformin is classified as a biguanide that reduces glucose production in the liver, delays intestinal glucose absorption, and improves the body's sensitivity to insulin.

Dosage of Jitodapa VIME 10/100/500 Tablet:

• Usage Directions

Take Jitodapa VIME 10/100/500 Tablet strictly according to your doctor’s instructions, following the prescribed dose and timing. Jitodapa VIME 10/100/500 Tablet should be swallowed whole with water and not chewed, cut, or crushed, preferably at the same time each day. Do not stop or alter the dose of Jitodapa VIME 10/100/500 Tablet without consulting your doctor, as this may prevent you from achieving the desired outcome. If you aren't sure how to take Jitodapa VIME 10/100/500, check with your healthcare provider or pharmacist for instructions.

• Missed Dose

If you accidentally skip your dose of Jitodapa VIME 10/100/500 Tablet, be sure to take it as soon as you remember later that day. If it's almost time for your dose, skip the missed dose and proceed with your usual routine. Stop taking double doses if you have forgotten one.

To help remember your daily dose, set phone alarms, use a pill organizer box, or use medication reminder apps.

• Overdose

If you take more than your prescribed dose of Jitodapa VIME 10/100/500 Tablet by mistake, seek immediate medical attention or reach out to a poison control center right away. An overdose can cause symptoms of hypoglycemia (low blood sugar), mild fever, swelling of hands and feet, or increased lipid profile.

Contraindications of Jitodapa VIME 10/100/500 Tablet:

Do not take Jitodapa VIME 10/100/500 Tablet if you have a known hypersensitivity or allergy to Vildagliptin, Dapagliflozin, Metformin, or any other ingredient in the medicine.

Additionally, it is strictly contraindicated for patients with type 1 diabetes mellitus, diabetic ketoacidosis, acute or chronic metabolic acidosis, and severe kidney impairment, kidney failure, or those undergoing dialysis.

Precautions & Warnings of Jitodapa VIME 10/100/500 Tablet:

Before starting Jitodapa VIME 10/100/500 Tablet, consult your healthcare provider and discuss your complete medical history, especially if you have a history of heart failure, moderate kidney or liver disease, pancreatitis, or recurrent urinary tract infections.

Caution is also required if you are prone to low blood sugar (hypoglycemia) or have persistent skin disorders, and your doctor will likely perform regular blood tests to monitor your kidney and liver function throughout your treatment.

Additionally, patients should be aware that the metformin component can rarely cause lactic acidosis—a serious medical emergency caused by a buildup of lactic acid—with the risk increasing during severe illnesses, dehydration, or excessive alcohol intake.

Side Effects of Jitodapa VIME 10/100/500 Tablet:

Like all medicines, Jitodapa VIME 10/100/500 Tablet can cause side effects, although not everyone will experience them. Common symptoms include hypoglycemia (low blood sugar), nausea, vomiting, diarrhea, abdominal pain, headache, dizziness, polydipsia, polyuria, and urinary tract infections.

However, seek immediate medical attention if you experience any rare or serious side effects, such as severe persistent abdominal pain spreading to the back (signs of pancreatitis), signs of severe allergic reactions (angioedema, swelling of face, lips, or throat), symptoms of lactic acidosis (extreme fatigue, rapid breathing, muscle pain), and severe dehydration.

Safety Related Concerns of Jitodapa VIME 10/100/500 Tablet:

• Pregnancy

Jitodapa VIME 10/100/500 Tablet is strictly contraindicated throughout pregnancy, as it may pose risks to the developing fetus and its safety during pregnancy has not been established. It is essential to inform your healthcare provider if you are pregnant, planning to become pregnant, or if you suspect you might be pregnant.

• Breastfeeding

It is best to avoid taking Jitodapa VIME 10/100/500 Tablet while breastfeeding, since the components may pass into breast milk and affect the nursing infant. Consult your healthcare provider before taking Jitodapa VIME 10/100/500 while nursing.

• Alcohol

Avoid heavy or chronic alcohol consumption while taking Jitodapa VIME 10/100/500 Tablet, as it significantly raises the risk of lactic acidosis and hypoglycemia.

• Food Interactions

Jitodapa VIME 10/100/500 Tablet may be taken with or without meals as advised by your physician. While there are no specific food-drug interactions that prevent this medication from working, following a consistent diabetic diet is essential for overall blood sugar management. It is suggested to avoid high-glycemic-index foods, sugary items, and refined carbohydrates, and to limit high-fat foods, as these are primarily responsible for sudden spikes in blood glucose.

Always discuss any severe gastrointestinal conditions, dietary restrictions, or food sensitivities with your healthcare provider to ensure optimal safety and efficacy.

• Drug Interactions

Jitodapa VIME 10/100/500 Tablet can interact with various medications, either by compromising their effectiveness or increasing the risk of toxicity. It is crucial to inform your healthcare provider if you are taking other anti-diabetic medications, such as insulin, or oral sulfonylureas, as this may increase the risk of low blood sugar, and dose adjustments may be necessary.

Additionally, caution is required when using medications like thiazides, corticosteroids, or diuretics, as these can increase the risk of fluid retention and swelling or interfere with blood sugar control.

Other drugs, including specific antibiotics like rifampicin, thyroid medications, carbonic anhydrase inhibitors, and ACE inhibitors, may also interact with the tablet.

Always provide your doctor with a complete list of all prescription medications, over-the-counter products, and supplements before starting treatment.

• Using Machinery & Driving

Using Jitodapa VIME 10/100/500 Tablet may cause lightheadedness, dizziness, or symptoms of hypoglycemia. Patients should use caution or avoid driving or operating machinery until they are sure the medication does not affect their alertness. Always carry a quick source of glucose, such as fruit juice or sugar tablets, and monitor your blood sugar regularly during treatment.

Storage of Jitodapa VIME 10/100/500 Tablet:

Store protected from light & moisture at a temperature not exceeding 30°C. Keep the medicine out of the reach of children.

Do not use this medication past the expiry date printed on the pack. Ensure expired or leftover medicines are disposed of safely and responsibly rather than thrown into household waste.

Helpful Tips:

• Combine medication adherence with a balanced, low-glycemic diet rich in fiber, whole grains, lean proteins, and vegetables.
• Regular exercise and strength training improve insulin sensitivity.
• Routine monitoring of blood glucose levels (both fasting and postprandial), periodic HbA1c testing, and maintaining proper hydration help maximize treatment outcomes.
• Continue taking your medication as prescribed, and do not discontinue it abruptly without your doctor's advice.
• Never share your medicine with others, even if they have similar symptoms.

Frequently Asked Questions (FAQs):

Q: Why is Jitodapa VIME 10/100/500 Tablet prescribed?

A: Jitodapa VIME 10/100/500 Tablet is prescribed for the management and treatment of type 2 diabetes mellitus in adults when diet, exercise, and single-agent therapies are not enough.

Q: Can I stop taking Jitodapa VIME 10/100/500 when my blood sugar levels normalize?

A: No, you should not stop taking the medication without consulting your healthcare provider. Diabetes is a chronic condition requiring long-term management. This medication helps control your blood sugar rather than curing the condition. Stopping it abruptly can cause your blood sugar levels to spike dangerously. Always consult your doctor before making any changes to your medication routine.

Q: What should I do if I experience low blood sugar (hypoglycemia)?

A: Hypoglycemia can occasionally occur with this medication. If you experience symptoms, immediately consume a fast-acting source of glucose—such as glucose tablets, fruit juice, or hard candy—and follow it up with a longer-acting snack or meal. Be sure to inform your doctor so they can evaluate and adjust your dosage if necessary.

Q: Does Jitodapa VIME 10/100/500 Tablet causes weight gain?

A: No, Jitodapa VIME 10/100/500 Tablet does not cause weight gain. Typically, the components like metformin, vildagliptin, and dapagliflozin are associated with weight neutrality or modest weight reduction rather than significant weight gain. However, if you experience rapid weight changes, consult your physician immediately.

Q: Can I exercise while taking Jitodapa VIME 10/100/500 Tablet?

A: Yes, regular physical activity is strongly encouraged as it helps improve insulin sensitivity and manage blood sugar levels. However, because exercise can lower blood glucose, be mindful of symptoms of low blood sugar (hypoglycemia) during or after intense workouts, and keep a fast-acting source of sugar nearby.

Q: Why is hydration important while taking Jitodapa VIME 10/100/500 Tablet?

A: The dapagliflozin component of this medication causes your kidneys to flush out excess sugar through urine, which can occasionally lead to increased urination and a risk of dehydration. Maintaining proper hydration by drinking adequate water throughout the day is essential to support kidney function and help prevent dizziness or low blood pressure.

References:

1. ENCELIN DM / TORGLIP DM 100/10/500. Vildagliptin, Dapagliflozin, and Metformin. Last Revised: JUN 2024. Accessed on: 11th September 2026. Click Here